Agenus | ApexOnco - Clinical Trials news and analysis

x

“It's very intuitive and always up-to-date”

Monika Vogelmann

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Conferences

4 September 2023

ESMO 2023 preview – going beyond PD-1

Deals

29 August 2023

Despite the setbacks, interest in TGF-β remains

Novartis looks set to hand nisevokitug rights back to Xoma, though plenty of work on TGF-β continues.

Subscribe to Agenus